Dr Axel Knebel came second in the Inaugural Gannochy Trust Innovation Award of the Royal Society of Edinburgh, which is awarded annually to a young entrepreneur under the age of 45 working in Scotland.
At the awards dinner held at Scone Palace near Perth, Scotland on 21 June 2003, Axel was presented with the silver medal by Lord Sutherland of Houndwood, the President of the Royal Society of Edinburgh. He shared the silver medal jointly with Dr Ian McEwan of the University of Aberdeen, while the winner was Dr Barbara Spruce, a former Princpal Investigator in the School of Life Sciences at Dundee, who now works in the Department of Surgery and Oncology in the Medical School at Ninewells Hospital, Dundee.
Axel was a postdoctoral fellow in the MRC Protein Phosphorylation Unit in the School of Life Sciences from 1998-2002. Working with Sir Philip Cohen over this period he developed a new method called KESTREL for identifying the substrates of protein kinases. In 2002 he became the founder and Managing Director of Kinasource Ltd, which is currently based in the Medical Sciences Institute of the School of Life Sciences. Kinasource commercialises the KESTREL technology, which has the potential to identify many novel drug targets.
The Gannochy Trust, based at Perth, is Scotland's second largest Charitable Trust.
The Royal Society of Edinburgh, is Scotland's National Academy for Science and the Arts. Founded in 1783 it is one of the oldest National Academies in the world.
At the awards dinner held at Scone Palace near Perth, Scotland on 21 June 2003, Axel was presented with the silver medal by Lord Sutherland of Houndwood, the President of the Royal Society of Edinburgh. He shared the silver medal jointly with Dr Ian McEwan of the University of Aberdeen, while the winner was Dr Barbara Spruce, a former Princpal Investigator in the School of Life Sciences at Dundee, who now works in the Department of Surgery and Oncology in the Medical School at Ninewells Hospital, Dundee.
Axel was a postdoctoral fellow in the MRC Protein Phosphorylation Unit in the School of Life Sciences from 1998-2002. Working with Sir Philip Cohen over this period he developed a new method called KESTREL for identifying the substrates of protein kinases. In 2002 he became the founder and Managing Director of Kinasource Ltd, which is currently based in the Medical Sciences Institute of the School of Life Sciences. Kinasource commercialises the KESTREL technology, which has the potential to identify many novel drug targets.
The Gannochy Trust, based at Perth, is Scotland's second largest Charitable Trust.
The Royal Society of Edinburgh, is Scotland's National Academy for Science and the Arts. Founded in 1783 it is one of the oldest National Academies in the world.